Gene Editing Experiment Halted as Patient Gets Weird Side Effects

Futurism

Lean Left

Mixed Factuality

Gene Editing Experiment Halted as Patient Gets Weird Side Effects

The experimental biotech startup Verve Therapeutics has paused the first phase of a buzzy human gene-editing trial due to strange side effects in a patient, according to a report from Bloomberg. The trial in question — dubbed the "Heart-1" trial — is the company's attempt to use gene editing to reduce heart-attack-causing cholesterol in patients with familial hypercholesterolemia, a passed-down genetic disorder that causes buildups of LDL choles…